Moderna jab designed to target original variant and Omicron has been given go-ahead by UK regulator
A vaccine designed to target two different forms of Covid will be offered as part of the autumn booster programme, after the jab was approved by the UK’s regulator.
Manufactured by US firm Moderna, the vaccine targets not only the original coronavirus – as is the case for vaccines currently in use – but is designed specifically to target the Omicron variant BA.1, which fuelled a wave of Covid in the UK last winter.
